Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$1.37 - $2.54 $8,326 - $15,438
-6,078 Reduced 15.24%
33,812 $85,000
Q4 2022

Feb 09, 2023

SELL
$1.67 - $2.51 $105,340 - $158,325
-63,078 Reduced 61.26%
39,890 $74,000
Q3 2022

Nov 09, 2022

BUY
$1.96 - $2.93 $111,833 - $167,179
57,058 Added 124.28%
102,968 $265,000
Q2 2022

Aug 11, 2022

BUY
$1.73 - $3.09 $78,732 - $140,625
45,510 Added 11377.5%
45,910 $89,000
Q1 2022

May 12, 2022

SELL
$2.94 - $4.77 $28,626 - $46,445
-9,737 Reduced 96.05%
400 $1,000
Q4 2021

Feb 11, 2022

SELL
$4.07 - $5.3 $17,008 - $22,148
-4,179 Reduced 29.19%
10,137 $46,000
Q3 2021

Nov 12, 2021

SELL
$4.7 - $7.24 $191,313 - $294,704
-40,705 Reduced 73.98%
14,316 $70,000
Q2 2021

Aug 10, 2021

BUY
$6.81 - $10.93 $246,528 - $395,676
36,201 Added 192.35%
55,021 $375,000
Q1 2021

May 12, 2021

SELL
$6.14 - $8.31 $749,583 - $1.01 Million
-122,082 Reduced 86.64%
18,820 $133,000
Q4 2020

Feb 10, 2021

BUY
$4.58 - $7.14 $259,163 - $404,024
56,586 Added 67.11%
140,902 $882,000
Q3 2020

Nov 12, 2020

BUY
$4.19 - $6.69 $269,630 - $430,508
64,351 Added 322.32%
84,316 $456,000
Q2 2020

Aug 13, 2020

SELL
$2.97 - $5.22 $1,167 - $2,051
-393 Reduced 1.93%
19,965 $104,000
Q1 2020

May 13, 2020

SELL
$2.67 - $4.97 $9,598 - $17,867
-3,595 Reduced 15.01%
20,358 $64,000
Q4 2019

Feb 10, 2020

BUY
$2.93 - $4.5 $39,944 - $61,348
13,633 Added 132.1%
23,953 $97,000
Q3 2019

Nov 12, 2019

BUY
$3.08 - $5.76 $25,989 - $48,602
8,438 Added 448.35%
10,320 $45,000
Q2 2019

Aug 09, 2019

BUY
$3.47 - $6.32 $6,530 - $11,894
1,882 New
1,882 $8,000
Q1 2018

May 11, 2018

SELL
$12.65 - $18.85 $202,235 - $301,354
-15,987 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$17.45 - $25.6 $217,165 - $318,592
-12,445 Reduced 43.77%
15,987 $286,000
Q3 2017

Nov 15, 2017

BUY
$18.9 - $28.2 $531,789 - $793,463
28,137 Added 9537.97%
28,432 $714,000
Q2 2017

Aug 14, 2017

BUY
N/A
295
295 $7,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.